Literature DB >> 29803282

Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Kathryn E Dickerson1, Neethu M Menon2, Ayesha Zia3.   

Abstract

Abnormal uterine bleeding is common in adolescents and is thought to affect 9% to 14% of women in their reproductive years. Certain unique aspects of underlying inherited or acquired blood disorders exacerbate the "expected" hormonal imbalance at this age, thereby increasing the morbidity of the underlying problem. A multifactorial etiology demands a collaborative approach between hematologists and gynecologists or adolescent medicine physicians to effectively manage abnormal uterine bleeding in young women with blood disorders.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abnormal uterine bleeding; Adolescents; Blood disorders; Heavy periods

Mesh:

Year:  2018        PMID: 29803282      PMCID: PMC5978747          DOI: 10.1016/j.pcl.2018.02.008

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  74 in total

1.  ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.

Authors: 
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

2.  Review of a multidisciplinary clinic for women with inherited bleeding disorders.

Authors:  C A Lee; C Chi; N Shiltagh; D Pollard; A Griffioen; N Dunn; R A Kadir
Journal:  Haemophilia       Date:  2008-08-08       Impact factor: 4.287

3.  Puberty menorrhagia requiring inpatient admission.

Authors:  A H Khosla; L Devi; P Goel; P K Saha
Journal:  JNMA J Nepal Med Assoc       Date:  2010 Apr-Jun       Impact factor: 0.406

4.  Pictorial blood loss assessment chart in the evaluation of heavy menstrual bleeding: diagnostic accuracy compared to alkaline hematin.

Authors:  Mahmoud S Zakherah; Gamal H Sayed; Sherif A El-Nashar; Mamdouh M Shaaban
Journal:  Gynecol Obstet Invest       Date:  2011-01-13       Impact factor: 2.031

5.  Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation.

Authors:  R Ghalie; C Porter; E Radwanska; W Fitzsimmons; C Richman; H Kaizer
Journal:  Am J Hematol       Date:  1993-04       Impact factor: 10.047

6.  Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.

Authors: 
Journal:  Lancet       Date:  1995-12-16       Impact factor: 79.321

7.  Intrauterine devices and pelvic inflammatory disease: an international perspective.

Authors:  T M Farley; M J Rosenberg; P J Rowe; J H Chen; O Meirik
Journal:  Lancet       Date:  1992-03-28       Impact factor: 79.321

8.  Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007.

Authors:  Leslie Raffini; Yuan-Shung Huang; Char Witmer; Chris Feudtner
Journal:  Pediatrics       Date:  2009-09-07       Impact factor: 7.124

9.  A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.

Authors:  C A Janssen; P C Scholten; A P Heintz
Journal:  Obstet Gynecol       Date:  1995-06       Impact factor: 7.661

10.  Menorrhagia I: measured blood loss, clinical features, and outcome in women with heavy periods: a survey with follow-up data.

Authors:  Pamela E Warner; Hilary O D Critchley; Mary Ann Lumsden; Mary Campbell-Brown; Anne Douglas; Gordon D Murray
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

View more
  2 in total

Review 1.  Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist.

Authors:  Sarah H O'Brien
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Diagnostic Value of Vaginal Ultrasound under Improved Clustering Algorithm Combined with Hysteroscopy in Abnormal Uterine Bleeding.

Authors:  Yuhui Wang; Qionghui Long
Journal:  Comput Intell Neurosci       Date:  2022-05-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.